Hepion Pharmaceuticals, Inc. (CTRVP) Total liabilities 2020–2023
Hepion Pharmaceuticals, Inc. (CTRVP) total liabilities at each fiscal year-end, per SEC filings.
$10.8MFY2023 · since FY2020: $8.1M → $10.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $10.8M | +4.1% |
| FY2022 | $10.4M | -1.6% |
| FY2021 | $10.6M | +29.9% |
| FY2020 | $8.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice